EUnetHTA Joint Action 3 (2016-20) JA3-WP4
2017 - PDF

This is the final project plan of the pharma JA on “Midostaurin with standard chemotherapy in FLT3 positive Acute Myeloid Leukaemia”. Included are the external comments on the project plan, including the authors’ answers to the comments.